Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Short Term Effects of Carbidopa-levodopa in Neovascular AMD
Authors not listed
Snyder, Robert W., M.D., Ph.D., P.C. · 2017
Abstract
From 3 large patient databases, patients diagnosed with AMD who have never taken levodopa(L-DOPA) containing medications have a mean age of diagnosis at 71 years. Patients who have been treated with L-DOPA containing medications have a mean age of diagnosis of AMD at 79 years.
L-DOPA binds to GPR143 in the retinal pigment epithelium, and releases PEDF, which protects the retina and downregulates VEGF, which is the cause of neovascularization.
The Investigators will evaluate the safety and tolerability of carbidopa-levodopa in patients with Neovascular AMD, and measure the effects on visual acuity and retinal abnormalities due to "wet" (neovascular) AMD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Anonymous. (2017). Short Term Effects of Carbidopa-levodopa in Neovascular AMD. <em>Snyder, Robert W., M.D., Ph.D., P.C.</em>. https://clinicaltrials.gov/study/NCT03022318
Vancouver
Anonymous. Short Term Effects of Carbidopa-levodopa in Neovascular AMD. Snyder, Robert W., M.D., Ph.D., P.C.. 2017.
BibTeX
@misc{anon2017ShortT,
title = {Short Term Effects of Carbidopa-levodopa in Neovascular AMD},
author = {Anonymous},
journal = {Snyder, Robert W., M.D., Ph.D., P.C.},
year = {2017},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Survey of Ophthalmology 1988
Open access · CC-BY
Age-related macular degeneration
Novartis Pharmaceuticals 2020
Open access · US-GOV
Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Age-related Macular Degeneration (AMD) Who Received Anti-vascular Endothelial Growth Factor (VEGF) Agents (Komodo Health)
Science 1997
Citation only
Mutation of the Stargardt Disease Gene ( ABCR ) in Age-Related Macular Degeneration
Molecular Interventions 2010
Preprint · OA
Age-related Macular Degeneration: Genetic and Environmental Factors of Disease
Washington University School of Medicine 2014
Open access · US-GOV
Intravitreal Rituximab
Sorlandet Hospital HF 2022
Open access · US-GOV